DoW Peer Reviewed Cancer, Idea Award

About this funding opportunity

Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Idea Award (IA) supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research. The advancement of knowledge in cancer research, patient care, and/or treatment options in the Military Health System (MHS) is critical to Service Members, Veterans, other military beneficiaries and the American public.

Distinctive Features: The proposed project should demonstrate creative thinking and innovation.

• Incremental advances, the next logical step, or switching a model system from one cancer to another cancer are not appropriate for this award.

• Inclusion of preliminary data is not required; however, the project must be based on strong scientific rationale.

• New for FY26: Early Career Investigator Option: The Early Career Investigator option is designed to support the continued development of promising independent investigators that are early in their faculty appointments.

Topic areas: General and Cross-cutting R&D, Life Sciences and Health, Security and Defense.

Funding amount

This grant provides Varies in funding.

Deadline

Applications are due Oct 05, 2026. Confirm the exact closing time on the official program page before applying.

Who can apply

This opportunity is open to the following applicant types:

• Open to all applicant types

Eligibility

The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.

Agency

DoW Peer Reviewed Cancer, Idea Award is administered by Defense Health Agency Contracting Activity - DHACA (AMRAA), listed via Grants.gov.